• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异环磷酰胺治疗患者的脑病。

Encephalopathy in ifosfamide-treated patients.

作者信息

Merimsky O, Reider-Groswasser I, Wigler N, Chaitchik S

机构信息

Department of Oncology, Ichilov Hospital, Sourasky Medical Center, Tel-Aviv University, Israel.

出版信息

Acta Neurol Scand. 1992 Nov;86(5):521-5. doi: 10.1111/j.1600-0404.1992.tb05136.x.

DOI:10.1111/j.1600-0404.1992.tb05136.x
PMID:1481635
Abstract

Acute encephalopathy following treatment with ifosfamide and mesna was observed in 5 (4 women and 1 men) of 28 patients (17.8%), with advanced sarcoma, lymphoma or ovarian carcinoma. This appeared within 2 to 7 days following the first dose of ifosfamide treatment, and included mental status changes, urinary incontinence, weakness, seizure activity, altered consciousness and psychiatric manifestations. Three cases were fatal, while two patients recovered completely. Brain CT and morphometric studies were normal in all the patients. Associated findings were myelosuppression, renal failure and electrolyte alterations.

摘要

在28例患有晚期肉瘤、淋巴瘤或卵巢癌的患者中,有5例(4名女性和1名男性,占17.8%)在接受异环磷酰胺和美司钠治疗后出现急性脑病。这在首次给予异环磷酰胺治疗后的2至7天内出现,症状包括精神状态改变、尿失禁、虚弱、癫痫活动、意识改变和精神症状。3例死亡,2例患者完全康复。所有患者的脑部CT和形态学研究均正常。相关表现为骨髓抑制、肾衰竭和电解质紊乱。

相似文献

1
Encephalopathy in ifosfamide-treated patients.异环磷酰胺治疗患者的脑病。
Acta Neurol Scand. 1992 Nov;86(5):521-5. doi: 10.1111/j.1600-0404.1992.tb05136.x.
2
Irreversible encephalopathy with ifosfamide/mesna.异环磷酰胺/美司钠所致不可逆性脑病
J Clin Oncol. 1987 Aug;5(8):1303-4. doi: 10.1200/JCO.1987.5.8.1303.
3
Ifosfamide and mesna: response and toxicity at standard- and high-dose schedules.异环磷酰胺与美司钠:标准剂量与高剂量方案下的疗效及毒性
Semin Oncol. 1990 Apr;17(2 Suppl 4):68-73.
4
Urinary proton magnetic resonance studies of early ifosfamide-induced nephrotoxicity and encephalopathy.早期异环磷酰胺诱导的肾毒性和脑病的尿质子磁共振研究。
Clin Cancer Res. 1997 Sep;3(9):1507-18.
5
Ifosfamide/mesa and encephalopathy.异环磷酰胺/美司钠与脑病
Lancet. 1985 Mar 30;1(8431):752. doi: 10.1016/s0140-6736(85)91288-7.
6
Severe renal failure following high-dose ifosfamide and mesna.大剂量异环磷酰胺和美司钠治疗后出现的严重肾衰竭。
Cancer Chemother Pharmacol. 1989;23(5):329-30. doi: 10.1007/BF00292414.
7
Avoiding ifosfamide/mesna encephalopathy.避免异环磷酰胺/美司钠脑病。
Lancet. 1986 Aug 16;2(8503):406. doi: 10.1016/s0140-6736(86)90099-1.
8
Prediction of ifosfamide/mesna associated encephalopathy.异环磷酰胺/美司钠相关性脑病的预测
Eur J Cancer Clin Oncol. 1986 Jul;22(7):815-9. doi: 10.1016/0277-5379(86)90368-8.
9
High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas.
J Clin Oncol. 1995 Jul;13(7):1600-8. doi: 10.1200/JCO.1995.13.7.1600.
10
Treatment of advanced malignancies with ifosfamide under protection with mesna.
Int J Clin Pharmacol Res. 1988;8(1):55-67.

引用本文的文献

1
Ifosfamide-Induced Encephalopathy in Children and Young Adults: The MD Anderson Cancer Center Experience.儿童和青年成人中的异环磷酰胺诱发的脑病:MD安德森癌症中心的经验
Cancers (Basel). 2025 Jun 29;17(13):2192. doi: 10.3390/cancers17132192.
2
Inflammatory Surrogate Parameters for Predicting Ifosfamide-Induced Neurotoxicity in Sarcoma Patients.用于预测肉瘤患者异环磷酰胺诱导神经毒性的炎症替代参数
J Clin Med. 2022 Sep 30;11(19):5798. doi: 10.3390/jcm11195798.
3
Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature.
大剂量异环磷酰胺所致脑病:一项回顾性队列研究及文献综述
Drug Saf. 2008;31(11):989-96. doi: 10.2165/00002018-200831110-00003.
4
Gender difference in ifosfamide metabolism by human liver microsomes.人肝微粒体对异环磷酰胺代谢的性别差异。
Eur J Drug Metab Pharmacokinet. 2001 Jul-Sep;26(3):193-200. doi: 10.1007/BF03190396.
5
Opioid and Nonopioid Therapy in Cancer Pain: The Traditional and the New.癌症疼痛的阿片类和非阿片类疗法:传统与新型疗法
Curr Rev Pain. 1999;3(3):237-247. doi: 10.1007/s11916-999-0018-9.
6
Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature.亚甲蓝治疗和预防异环磷酰胺所致脑病:12例报告及文献复习
Br J Cancer. 2000 Jan;82(2):291-4. doi: 10.1054/bjoc.1999.0917.
7
Delayed, transient encephalopathy after marrow transplantation: case reports and MRI findings in four patients.骨髓移植后迟发性短暂性脑病:4例患者的病例报告及MRI表现
J Neurooncol. 1996 Mar;27(3):241-50. doi: 10.1007/BF00165481.
8
Pharmacokinetically guided dosing of carboplatin and etoposide during peritoneal dialysis and haemodialysis.腹膜透析和血液透析期间卡铂和依托泊苷的药代动力学指导给药
Br J Cancer. 1996 Mar;73(6):776-80. doi: 10.1038/bjc.1996.135.